These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 30424780)
21. Preclinical evaluation of (S)-[ Ramakrishnan NK; Hird M; Thompson S; Williamson DJ; Qiao L; Owen DR; Brooks AF; Scott PJH; Bacallado S; O'Brien JT; Aigbirhio FI Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):125-136. PubMed ID: 34405276 [TBL] [Abstract][Full Text] [Related]
22. The P2X Hagens MHJ; Golla SSV; Janssen B; Vugts DJ; Beaino W; Windhorst AD; O'Brien-Brown J; Kassiou M; Schuit RC; Schwarte LA; de Vries HE; Killestein J; Barkhof F; van Berckel BNM; Lammertsma AA Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):379-389. PubMed ID: 31705174 [TBL] [Abstract][Full Text] [Related]
23. [18F]DPA-714 PET imaging of translocator protein TSPO (18 kDa) in the normal and excitotoxically-lesioned nonhuman primate brain. Lavisse S; Inoue K; Jan C; Peyronneau MA; Petit F; Goutal S; Dauguet J; Guillermier M; Dollé F; Rbah-Vidal L; Van Camp N; Aron-Badin R; Remy P; Hantraye P Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):478-94. PubMed ID: 25488184 [TBL] [Abstract][Full Text] [Related]
24. Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. Arlicot N; Vercouillie J; Ribeiro MJ; Tauber C; Venel Y; Baulieu JL; Maia S; Corcia P; Stabin MG; Reynolds A; Kassiou M; Guilloteau D Nucl Med Biol; 2012 May; 39(4):570-8. PubMed ID: 22172392 [TBL] [Abstract][Full Text] [Related]
25. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Park E; Gallezot JD; Delgadillo A; Liu S; Planeta B; Lin SF; O'Connor KC; Lim K; Lee JY; Chastre A; Chen MK; Seneca N; Leppert D; Huang Y; Carson RE; Pelletier D Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1081-92. PubMed ID: 25833352 [TBL] [Abstract][Full Text] [Related]
26. Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA. Suridjan I; Rusjan PM; Voineskos AN; Selvanathan T; Setiawan E; Strafella AP; Wilson AA; Meyer JH; Houle S; Mizrahi R Neuroimage; 2014 Jan; 84():868-75. PubMed ID: 24064066 [TBL] [Abstract][Full Text] [Related]
27. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET. Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727 [TBL] [Abstract][Full Text] [Related]
28. Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities. Rizzo G; Veronese M; Tonietto M; Bodini B; Stankoff B; Wimberley C; Lavisse S; Bottlaender M; Bloomfield PS; Howes O; Zanotti-Fregonara P; Turkheimer FE; Bertoldo A J Cereb Blood Flow Metab; 2019 May; 39(5):874-885. PubMed ID: 29135382 [TBL] [Abstract][Full Text] [Related]
29. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET. Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575 [TBL] [Abstract][Full Text] [Related]
30. Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Herranz E; Treaba CA; Barletta VT; Mehndiratta A; Ouellette R; Sloane JA; Ionete C; Babu S; Mastantuono M; Magon S; Loggia ML; Makary MM; Hooker JM; Catana C; Kinkel RP; Nicholas R; Klawiter EC; Magliozzi R; Mainero C Brain; 2024 Jul; 147(7):2566-2578. PubMed ID: 38289855 [TBL] [Abstract][Full Text] [Related]
31. TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study. Van Weehaeghe D; Van Schoor E; De Vocht J; Koole M; Attili B; Celen S; Declercq L; Thal DR; Van Damme P; Bormans G; Van Laere K J Nucl Med; 2020 Apr; 61(4):604-607. PubMed ID: 31562223 [TBL] [Abstract][Full Text] [Related]
32. Ottoy J; De Picker L; Verhaeghe J; Deleye S; Wyffels L; Kosten L; Sabbe B; Coppens V; Timmers M; van Nueten L; Ceyssens S; Stroobants S; Morrens M; Staelens S J Nucl Med; 2018 Aug; 59(8):1267-1274. PubMed ID: 29326362 [TBL] [Abstract][Full Text] [Related]
33. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA. Suridjan I; Rusjan PM; Kenk M; Verhoeff NP; Voineskos AN; Rotenberg D; Wilson AA; Meyer JH; Houle S; Mizrahi R Synapse; 2014 Nov; 68(11):536-47. PubMed ID: 25043159 [TBL] [Abstract][Full Text] [Related]
34. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106. Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062 [TBL] [Abstract][Full Text] [Related]
36. Comparison of 18F-fluoro-deoxy-glucose, 18F-fluoro-methyl-choline, and 18F-DPA714 for positron-emission tomography imaging of leukocyte accumulation in the aortic wall of experimental abdominal aneurysms. Sarda-Mantel L; Alsac JM; Boisgard R; Hervatin F; Montravers F; Tavitian B; Michel JB; Le Guludec D J Vasc Surg; 2012 Sep; 56(3):765-73. PubMed ID: 22726755 [TBL] [Abstract][Full Text] [Related]
37. In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA. Suridjan I; Pollock BG; Verhoeff NP; Voineskos AN; Chow T; Rusjan PM; Lobaugh NJ; Houle S; Mulsant BH; Mizrahi R Mol Psychiatry; 2015 Dec; 20(12):1579-87. PubMed ID: 25707397 [TBL] [Abstract][Full Text] [Related]
38. In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients. Varrone A; Mattsson P; Forsberg A; Takano A; Nag S; Gulyás B; Borg J; Boellaard R; Al-Tawil N; Eriksdotter M; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Lammertsma AA; Halldin C Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):921-31. PubMed ID: 23436070 [TBL] [Abstract][Full Text] [Related]
39. Microglial activation in Parkinson's disease using [ Ghadery C; Koshimori Y; Coakeley S; Harris M; Rusjan P; Kim J; Houle S; Strafella AP J Neuroinflammation; 2017 Jan; 14(1):8. PubMed ID: 28086916 [TBL] [Abstract][Full Text] [Related]
40. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging. Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M; Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]